THERAPEUTIC POTENTIAL OF DUAL PI3K DELTA/GAMMA INHIBITION IN T-CELL LYMPHOMAS

被引：0
|
作者：
Vakkalanka, S. [1 ]
Viswanadha, S. [2 ]
Govindarajulu, B. [3 ]
Prasanna, R. [4 ,5 ]
Veeraraghavan, S.
Nagarathnam, D. [6 ]
机构：
[1] Rhizen Pharmaceut SA, Gen Adm, La Chaux De Fonds, Switzerland
[2] Incozen Therapeut Pvt Ltd, Drug Discovery, Hyderabad, Telangana, India
[3] Incozen Therapeut Pvt Ltd, Med Chem, Hyderabad, Telangana, India
[4] Incozen Therapeut Pvt Ltd, Biol Res, Hyderabad, Telangana, India
[5] Incozen Therapeut Pvt Ltd, Pharmacokinet, Hyderabad, Telangana, India
[6] DNSK Int, Chem, Hamden, CT USA
来源：
HAEMATOLOGICA | 2013年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P985
引用
收藏
页码：407 / 407
页数：1
相关论文
共 50 条
  • [1] PI3K Inhibition As a Potential Therapeutic Strategy in Peripheral T-Cell Lymphomas
    Martin-Sanchez, Esperanza
    Rodriguez-Pinilla, Socorro M.
    Lombardia, Luis
    Dominguez-Gonzalez, Beatriz
    Sanchez-Beato, Margarita
    Romero, Diana
    Wozniak, Magdalena B.
    Mollejo, Manuela
    Alves, Javier
    Luis Rodriguez-Peralto, Jose
    Menarguez, Javier
    Cigudosa, Juan C.
    Ortiz-Romero, Pablo L.
    Garcia, Juan F.
    Bischoff, James R.
    Piris, Miguel A.
    BLOOD, 2011, 118 (21) : 1490 - 1491
  • [2] A requirement for PI3K in gamma delta T-cell development
    Sumaria, N.
    Grandjean, C. L. A.
    Pang, D. J.
    Neves, J. F.
    Stoenchev, K. V.
    Silva-Santos, B.
    Pennington, D. J.
    IMMUNOLOGY, 2014, 143 : 53 - 53
  • [3] Dual inhibition of CDK9 and PI3K addresses mutual resistance mechanisms in T-cell lymphomas
    Ksionsko, N.
    Nothnick, G.
    Conrads, K.
    Ries, L.
    Salinas, G.
    Haubrock, M.
    Beissbarth, T.
    Koch, R.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 220 - 220
  • [4] Dual Inhibition of PI3K Delta and PI3K Gamma Isoforms to Prevent Graft-Versus-Host Disease By Limiting T Cell Expansion In Vivo
    Wang, Shuhua
    Passang, Tenzin
    Li, Yiwen
    Zhang, Hanwen
    Das, Pankoj Kumar
    Chen, Kevin
    Funk, Christopher R.
    Waller, Edmund K.
    BLOOD, 2022, 140 : 10219 - 10220
  • [5] Gamma-delta T-cell lymphomas
    Claudio Tripodo
    Emilio Iannitto
    Ada Maria Florena
    Carlo Ennio Pucillo
    Pier Paolo Piccaluga
    Vito Franco
    Stefano Aldo Pileri
    Nature Reviews Clinical Oncology, 2009, 6 : 707 - 717
  • [6] Gamma-delta t-cell lymphomas
    Foppoli, Marco
    Ferreri, Andres J. M.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2015, 94 (03) : 206 - 218
  • [7] Gamma-delta T-cell lymphomas
    Tripodo, Claudio
    Iannitto, Emilio
    Florena, Ada Maria
    Pucillo, Carlo Ennio
    Piccaluga, Pier Paolo
    Franco, Vito
    Pileri, Stefano Aldo
    NATURE REVIEWS CLINICAL ONCOLOGY, 2009, 6 (12) : 707 - 717
  • [8] DUAL INHIBITION OF PHOSPHATIDYLINOSITOL 3-KINASE (PI3K) AND mTOR AS A NEW THERAPEUTIC OPTION FOR T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (T-ALL)
    Chiarini, F.
    Grimaldi, C.
    Tazzari, P. L.
    Ricci, F.
    Pagliaro, P.
    Martelli, A. M.
    CYTOMETRY PART A, 2010, 77A (02) : 167 - 167
  • [9] Gamma-delta peripheral T-cell lymphomas
    de Andres, SA
    Montejano, FH
    MEDICINA CLINICA, 1998, 111 (05): : 177 - 178
  • [10] Dual PI3K delta/gamma inhibition by RP6530 accentuates bortezomib activity in multiple myeloma cell lines
    Viswanadha, S.
    Babu, G.
    Veeraraghavan, S.
    Vakkalanka, S.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 108 - 108
12345